Consensus Quanterix Corporation

Equities

QTRX

US74766Q1013

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 12:59:43 2026-03-05 pm EST			5-day change	1st Jan Change
5.285 ^USD	-9.81%		-20.83%	-16.35%

Mar. 02	Quanterix Corporation, Q4 2025 Earnings Call, Mar 02, 2026
Mar. 02	Quanterix Corporation Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI

Evolution of the Average Target: Quanterix Corporation

Evolution of the Target Price: Quanterix Corporation

Changes in Analyst Recommendations: Quanterix Corporation

dab8044112d56e044c81ae4.dh2WoZRH1Yz8zVxj840Xa8g_8eRZ4D_T25AGOGzsnFE.I1v41fo_nu-qrg40y7g6P_pIvLI_olKEqKY-bCmq82M9Vv2V-QKKw821FQ~b4070654ad906a8322099aef20ff0dfe

Analysts' recommendations: Quanterix Corporation

25-08-11	Quanterix Shares Drop After Canaccord Genuity Downgrade	MT
25-08-11	Canaccord Genuity Downgrades Quanterix to Hold From Buy, Adjusts Price Target to $5 From $12	MT
25-04-30	Leerink Partners Downgrades Quanterix to Market Perform From Outperform, Lowers Price Target to $8 From $12	MT
24-07-09	Goldman Sachs Adjusts Price Target on Quanterix to $24 From $35, Maintains Buy Rating	MT
24-04-29	Canaccord Genuity Adjusts Price Target on Quanterix to $25 From $32, Maintains Buy Rating	MT
24-03-04	Scotiabank Raises Price Target on Quanterix to $32 From $30, Keeps Sector Outperform Rating	MT
23-09-27	Goldman Sachs Raises Price Target on Quanterix to $34 From $30, Maintains Buy Rating	MT
23-09-25	Canaccord Genuity Upgrades Quanterix to Buy From Hold, Raises Price Target to $32 From $25	MT
23-08-09	SVB Securities Upgrades Quanterix to Outperform From Market Perform, Raises Price Target to $30 From $25	MT
23-08-09	Goldman Sachs Raises Price Target on Quanterix to $30 From $27, Maintains Buy Rating	MT
23-05-23	Goldman Sachs Upgrades Quanterix to Buy From Neutral, Boosts Price Target to $27 From $13	MT
22-11-10	Goldman Sachs Adjusts Price Target on Quanterix to $13 From $15, Maintains Neutral Rating	MT
22-08-15	Canaccord Genuity Downgrades Quanterix to Hold From Buy	MT
22-08-10	Goldman Sachs Cuts Price Target on Quanterix to $15 From $25, Maintains Neutral Rating	MT
22-08-09	Cowen Downgrades Quanterix to Market Perform from Outperform, Adjusts Price Target to $18 from $38	MT
22-08-09	SVB Securities Downgrades Quanterix to Market Perform From Outperform, Adjusts Price Target to $15 From $35	MT
22-07-14	Goldman Sachs Adjusts Quanterix's Price Target to $25 from $30, Keeps Neutral Rating	MT
22-05-11	Goldman Sachs Adjusts Quanterix Price Target to $30 From $35, Maintains Neutral Rating	MT
22-05-11	SVB Securities Adjusts Quanterix's Price Target to $35 from $50, Keeps Outperform Rating	MT
22-04-13	Goldman Sachs Adjusts Quanterix's Price Target to $35 from $40, Keeps Neutral Rating	MT
22-03-15	BTIG Adjusts Price Target on Quanterix to $60 From $92, Reiterates Buy Rating	MT
22-03-02	JPMorgan Adjusts Quanterix Price Target to $60 From $85, Maintains Overweight Rating	MT
22-03-02	SVB Leerink Adjusts Quanterix's Price Target to $50 from $70, Keeps Outperform Rating	MT
22-03-02	Goldman Sachs Upgrades Quanterix to Neutral From Sell; Price Target is $40	MT
21-08-05	QUANTERIX : Canaccord Genuity Adjusts Price Target on Quanterix to $75 From $90, Maintains Buy Rating	MT

More recommendations

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Analysts' recommendations evolution (4 months)	Objective/dr gap
QUANTERIX CORPORATION	-	+25.14%
THERMO FISHER SCIENTIFIC, INC.		+29.99%
INTUITIVE SURGICAL, INC.		+21.68%
DANAHER CORPORATION		+29.39%
BOSTON SCIENTIFIC CORPORATION		+44.36%
SIEMENS HEALTHINEERS AG		+33.84%
EDWARDS LIFESCIENCES CORPORATION		+13.19%
RESMED, INC.		+14.83%
GE HEALTHCARE TECHNOLOGIES INC.		+18.01%
AGILENT TECHNOLOGIES, INC.		+34.16%
Average		+26.46%
Weighted average by Cap.		+28.17%